Reply to Roemer and Guermazi: Early biochemical changes on MRI can predict risk of symptomatic progression

Shinjini Kundu; Beth G. Ashinsky; Mustapha Bouhrara; Erik B. Damd; Shadpour Demehri; M. Shifat-E-Rabbi; Richard G. Spencer; Kenneth L. Urish; Gustavo K. Rohde

doi:10.1073/pnas.2024679118

Reply to Roemer and Guermazi: Early biochemical changes on MRI can predict risk of symptomatic progression

Shinjini Kundu, Beth G. Ashinsky, Mustapha Bouhrara, Erik B. Damd, Shadpour Demehri, M. Shifat-E-Rabbi, Richard G. Spencer, Kenneth L. Urish, Gustavo K. Rohde

School of Medicine

Research output: Contribution to journal › Letter › peer-review

Original language	English (US)
Article number	e2024679118
Journal	Proceedings of the National Academy of Sciences of the United States of America
Volume	118
Issue number	11
DOIs	https://doi.org/10.1073/pnas.2024679118
State	Published - Mar 16 2021

ASJC Scopus subject areas

General

Access to Document

10.1073/pnas.2024679118

Cite this

Kundu, S., Ashinsky, B. G., Bouhrara, M., Damd, E. B., Demehri, S., Shifat-E-Rabbi, M., Spencer, R. G., Urish, K. L., & Rohde, G. K. (2021). Reply to Roemer and Guermazi: Early biochemical changes on MRI can predict risk of symptomatic progression. Proceedings of the National Academy of Sciences of the United States of America, 118(11), Article e2024679118. https://doi.org/10.1073/pnas.2024679118

Kundu, S, Ashinsky, BG, Bouhrara, M, Damd, EB, Demehri, S, Shifat-E-Rabbi, M, Spencer, RG, Urish, KL & Rohde, GK 2021, 'Reply to Roemer and Guermazi: Early biochemical changes on MRI can predict risk of symptomatic progression', Proceedings of the National Academy of Sciences of the United States of America, vol. 118, no. 11, e2024679118. https://doi.org/10.1073/pnas.2024679118

@article{b72b7f98031f4deb98ea9f70a077f310,

title = "Reply to Roemer and Guermazi: Early biochemical changes on MRI can predict risk of symptomatic progression",

author = "Shinjini Kundu and Ashinsky, {Beth G.} and Mustapha Bouhrara and Damd, {Erik B.} and Shadpour Demehri and M. Shifat-E-Rabbi and Spencer, {Richard G.} and Urish, {Kenneth L.} and Rohde, {Gustavo K.}",

year = "2021",

month = mar,

day = "16",

doi = "10.1073/pnas.2024679118",

language = "English (US)",

volume = "118",

journal = "Proceedings of the National Academy of Sciences of the United States of America",

issn = "0027-8424",

publisher = "National Academy of Sciences",

number = "11",

}

TY - JOUR

T1 - Reply to Roemer and Guermazi

T2 - Early biochemical changes on MRI can predict risk of symptomatic progression

AU - Kundu, Shinjini

AU - Ashinsky, Beth G.

AU - Bouhrara, Mustapha

AU - Damd, Erik B.

AU - Demehri, Shadpour

AU - Shifat-E-Rabbi, M.

AU - Spencer, Richard G.

AU - Urish, Kenneth L.

AU - Rohde, Gustavo K.

PY - 2021/3/16

Y1 - 2021/3/16

UR - http://www.scopus.com/inward/record.url?scp=85102350487&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85102350487&partnerID=8YFLogxK

U2 - 10.1073/pnas.2024679118

DO - 10.1073/pnas.2024679118

M3 - Letter

C2 - 33836609

AN - SCOPUS:85102350487

SN - 0027-8424

VL - 118

JO - Proceedings of the National Academy of Sciences of the United States of America

JF - Proceedings of the National Academy of Sciences of the United States of America

IS - 11

M1 - e2024679118

ER -

Reply to Roemer and Guermazi: Early biochemical changes on MRI can predict risk of symptomatic progression

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this